Teladoc Stock News

After a sharp selloff on Wednesday, virtual care companies, Teladoc <> and American Well <> trading higher as U.S

Wednesday''s top analyst upgrades and downgrades included Advanced Micro Devices, Annaly Capital Management, Clorox, Constellation Energy, Li Auto, Penn National Gaming, Teladoc Health, Transocean and Zimmer Biomet.

Amazon joins CVS, Teladoc, and Walgreens when it comes to trying to change how American’s get their basic healthcare.

Virtual care companies, Teladoc <>, American Well <> and Hims & Hers Health <> are trading lower on Tuesday after e-commerce giant Amazon (AMZN) announced a…

A day after Bank of America lowered its price target on Teladoc Health <> by as much as a third, Piper Sandler has followed suit. Citing a bleak outlook for the companys

The telemedicine market is poised for substantial growth, and Teladoc''s revenues are robust. So maybe, TDOC stock is finally ready to run.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips The telemedicine market is poised for substantial growth, and Teladoc''s revenues are robust. So maybe, TDOC stock is finally ready to run. The post Feeling Bold? Check Out Teladoc Health While It’s Still Oversold appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…

After a brief uptick on Monday, Teladoc Health <> turned lower in reaction to a bearish outlook painted by Bank of America as the telehealth provider prepares to announce its Q4

Kemper Corporation (NYSE: KMPR ) announced that its Board of Directors has elected Jason Gorevic as a Director, effective February 2. The Board also announced that David P. Storch has informed the Board of his intention to retire as a director at the end of his current term, expiring May 4, 2022. As Chief Executive Officer of Teladoc Health, the global leader in whole-person virtual care, and a member of Teladoc''s Board of Directors, Gorevic has delivered exponential growth in revenue, membership and care visits over his twelve-year tenure. He has over 25 years of experience in the healthcare industry and in 2021 was named one of the most influential people in healthcare by Modern Healthcare magazine. He has served in senior leadership roles at Wellpoint, Inc. (now Anthem, Inc.), including Chief Marketing & Product Officer and President of Empire Blue Cross Blue Shield. Gorevic has a Bachelor of Arts degree in International Relations from the University of Pennsylvania. "We''re pleased to welcome Jason to our board," said Joseph P.

Matthew Tuttle Timed His Anti-ARKK ETF Perfectly And Has $350 Million In Inflows To Show For It Over the last couple of weeks, we have written extensively about the plunge in Cathie Wood''s flagship "Innovation" ARKK fund. But it''s the man who is making money while ARKK flounders that we haven''t covered at length. That man is Matthew Tuttle, who first had the idea to start an ETF betting against Wood''s flagship fund when he saw the idea on Twitter last year, according to a new article from Yahoo . The 53 year old thought to himself at the time: Holy crap, thats a great idea. In the following weeks, he filed for The Tuttle Capital Short Innovation ETF, ticker SARK, which would seek to bet against Wood''s fund using swaps contracts. Since its inception, the fund is up almost 60% while ARKK has fallen more than 40%. In other words, Tuttle''s timing was incredible. His fund has seen inflows of $298 million while a net $92 million has been pulled from ARKK over the same time period, Yahoo reported.

Teladoc Health Inc (TDOC) shares closed today at 0.8% above its 52 week low of $66.93, giving the company a market cap of $11B. The stock is currently down 24.2% year-to-date, down 75.7% over the past 12 months, and up 255.9% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 13.2% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.4. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 1275.0% The company's stock price performance over the past 12 months lags the peer average by -535.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

They both skyrocketed early in the pandemic.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Teladoc is worth at least $110 a share assuming its revenue grows at historical rates for the next few years. The post Teladoc Stock Is Due for a Major Upside Reversal appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Man Who Called Black Monday: “Prepare Now.” #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First…